These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 12925698

  • 1. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, Miatkowski K, Benjamin C, Normanno N, Williams KP, Jarpe M, LePage D, Salomon D, Sanicola M.
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [Abstract] [Full Text] [Related]

  • 2. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC, Harrison CA, Vale W.
    Proc Natl Acad Sci U S A; 2003 Apr 29; 100(9):5193-8. PubMed ID: 12682303
    [Abstract] [Full Text] [Related]

  • 3. Decrypting the role of Cripto in tumorigenesis.
    Shen MM.
    J Clin Invest; 2003 Aug 29; 112(4):500-2. PubMed ID: 12925690
    [Abstract] [Full Text] [Related]

  • 4. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU, de Gorter DJ, Aartsma-Rus A, van Ommen GJ, ten Dijke P, 't Hoen PA, Hoogaars WM.
    FASEB J; 2012 Apr 29; 26(4):1462-72. PubMed ID: 22202673
    [Abstract] [Full Text] [Related]

  • 5. Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor.
    Calvanese L, Saporito A, Oliva R, D' Auria G, Pedone C, Paolillo L, Ruvo M, Marasco D, Falcigno L.
    J Pept Sci; 2009 Mar 29; 15(3):175-83. PubMed ID: 19035567
    [Abstract] [Full Text] [Related]

  • 6. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
    Kelber JA, Shani G, Booker EC, Vale WW, Gray PC.
    J Biol Chem; 2008 Feb 22; 283(8):4490-500. PubMed ID: 18089557
    [Abstract] [Full Text] [Related]

  • 7. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L, Bianco C, Normanno N, Salomon D.
    Oncogene; 2005 Aug 29; 24(37):5731-41. PubMed ID: 16123806
    [Abstract] [Full Text] [Related]

  • 8. Cripto monoclonal antibodies.
    Hu XF, Xing PX.
    Drug News Perspect; 2005 Jun 29; 18(5):293-303. PubMed ID: 16193101
    [Abstract] [Full Text] [Related]

  • 9. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
    Bianco C, Strizzi L, Rehman A, Normanno N, Wechselberger C, Sun Y, Khan N, Hirota M, Adkins H, Williams K, Margolis RU, Sanicola M, Salomon DS.
    Cancer Res; 2003 Mar 15; 63(6):1192-7. PubMed ID: 12649175
    [Abstract] [Full Text] [Related]

  • 10. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
    Foley SF, van Vlijmen HW, Boynton RE, Adkins HB, Cheung AE, Singh J, Sanicola M, Young CN, Wen D.
    Eur J Biochem; 2003 Sep 15; 270(17):3610-8. PubMed ID: 12919325
    [Abstract] [Full Text] [Related]

  • 11. Cripto localizes Nodal at the limiting membrane of early endosomes.
    Blanchet MH, Le Good JA, Oorschot V, Baflast S, Minchiotti G, Klumperman J, Constam DB.
    Sci Signal; 2008 Nov 11; 1(45):ra13. PubMed ID: 19001664
    [Abstract] [Full Text] [Related]

  • 12. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
    Liguori GL, Borges AC, D'Andrea D, Liguoro A, Gonçalves L, Salgueiro AM, Persico MG, Belo JA.
    Dev Biol; 2008 Mar 15; 315(2):280-9. PubMed ID: 18241853
    [Abstract] [Full Text] [Related]

  • 13. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S, D'Andrea D, Lago CT, Adamson ED, Persico MG, Minchiotti G.
    J Cell Biol; 2003 Oct 27; 163(2):303-14. PubMed ID: 14581455
    [Abstract] [Full Text] [Related]

  • 14. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
    Yeo C, Whitman M.
    Mol Cell; 2001 May 27; 7(5):949-57. PubMed ID: 11389842
    [Abstract] [Full Text] [Related]

  • 15. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
    Yan YT, Liu JJ, Luo Y, E C, Haltiwanger RS, Abate-Shen C, Shen MM.
    Mol Cell Biol; 2002 Jul 27; 22(13):4439-49. PubMed ID: 12052855
    [Abstract] [Full Text] [Related]

  • 16. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC, Shani G, Aung K, Kelber J, Vale W.
    Mol Cell Biol; 2006 Dec 27; 26(24):9268-78. PubMed ID: 17030617
    [Abstract] [Full Text] [Related]

  • 17. Cripto: a novel target for antibody-based cancer immunotherapy.
    Xing PX, Hu XF, Pietersz GA, Hosick HL, McKenzie IF.
    Cancer Res; 2004 Jun 01; 64(11):4018-23. PubMed ID: 15173016
    [Abstract] [Full Text] [Related]

  • 18. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
    Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, De Luca A, Sun Y, Khan N, Kenney N, Ebert A, Williams KP, Sanicola M, Salomon DS.
    Mol Cell Biol; 2002 Apr 01; 22(8):2586-97. PubMed ID: 11909953
    [Abstract] [Full Text] [Related]

  • 19. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
    Chu J, Ding J, Jeays-Ward K, Price SM, Placzek M, Shen MM.
    Development; 2005 Dec 01; 132(24):5539-51. PubMed ID: 16291788
    [Abstract] [Full Text] [Related]

  • 20. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.
    Harms PW, Chang C.
    Genes Dev; 2003 Nov 01; 17(21):2624-9. PubMed ID: 14563676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.